The Cutting Edge of Medical Technology Content, Community & Collaboration
Eli Lilly, Cornell, and Kauffman Foundation Unveil New Web-Based Tech Transfer Initiatives
Colleagues,
As reported in GenomeWeb Biotech Transfer Week...Eli Lilly, Cornell University, and the Kauffman Foundation's iBridge Network each unveiled separate web-based initiatives last week designed to bolster university technology commercialization by making it easier for academic and industrial researchers to partner.
The Eli Lilly tool will allow external researchers at academic institutions or small biotech companies to submit their compounds free of charge via a web portal to the pharma giant, which will conduct phenotypic, disease-relevant screens on the chemicals in hopes of uncovering potential areas of further collaboration. The Lilly program, called Phenotypic Drug Discovery, or PD2, is not yet active but should be by April. According to Lilly, at least six academic institutions are working with the company as pilot participants in PD2: the Swiss Federal Institute of Technology, Kansas University, Purdue University, Scripps Florida, the University of Notre Dame, and the University of Pittsburgh.
The Cornell University portal called MyIP allows faculty inventors to better manage their intellectual property portfolio; MyIP provides faculty, staff, and student inventors with a secure account and the ability to view the patent, licensing, and marketing status for each of their inventions. The site also allows staff to create new inventor accounts, update inventor status, pull usage reports, and change announcements and other site content.
A redesigned version of the iBridge Network was also launched. iBridge Network, is an online university innovation marketplace developed and launched nearly two years ago by The Kauffman Foundation, a non-profit entrepreneurial education group. 68 US universities or non-profit research universities currently list their technologies on iBridge, the number of technologies listed on the site is about 5,650. The site is free to both those offering technologies and shopping for technologies.
ENJOY!
CC
As reported in GenomeWeb Biotech Transfer Week...Eli Lilly, Cornell University, and the Kauffman Foundation's iBridge Network each unveiled separate web-based initiatives last week designed to bolster university technology commercialization by making it easier for academic and industrial researchers to partner.
The Eli Lilly tool will allow external researchers at academic institutions or small biotech companies to submit their compounds free of charge via a web portal to the pharma giant, which will conduct phenotypic, disease-relevant screens on the chemicals in hopes of uncovering potential areas of further collaboration. The Lilly program, called Phenotypic Drug Discovery, or PD2, is not yet active but should be by April. According to Lilly, at least six academic institutions are working with the company as pilot participants in PD2: the Swiss Federal Institute of Technology, Kansas University, Purdue University, Scripps Florida, the University of Notre Dame, and the University of Pittsburgh.
The Cornell University portal called MyIP allows faculty inventors to better manage their intellectual property portfolio; MyIP provides faculty, staff, and student inventors with a secure account and the ability to view the patent, licensing, and marketing status for each of their inventions. The site also allows staff to create new inventor accounts, update inventor status, pull usage reports, and change announcements and other site content.
A redesigned version of the iBridge Network was also launched. iBridge Network, is an online university innovation marketplace developed and launched nearly two years ago by The Kauffman Foundation, a non-profit entrepreneurial education group. 68 US universities or non-profit research universities currently list their technologies on iBridge, the number of technologies listed on the site is about 5,650. The site is free to both those offering technologies and shopping for technologies.
ENJOY!
CC
Views: 31
Comment
MedTechIQ VideoLibrary
Upcoming Events
© 2024 Created by CC-Conrad Clyburn-MedForeSight.
Powered by
You need to be a member of MedTech I.Q. to add comments!
Join MedTech I.Q.